The reduction in CCT subunits and HSP90 in COPD and asthma EVs suggests that collective decline in tissue proteostasis mediators may be indicative of chaperone system exhaustion, with a potential role as biomarkers of disease progression or response to treatment. The gene discussed is FLVCR2; the disease is asthma.